Armstrong Advisory Group’s Thermo Fisher Scientific TMO Stock Holding History

Armstrong Advisory Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$739K	Buy	1,095 +90	+9%	+$53.5K	0.04%	112
2026 Q2	$504K	Sell	1,005 -2	-0.2%	-$960	0.03%	146
2026 Q1	$495K	Sell	1,007 -34	-3%	-$18.5K	0.03%	140
2025 Q4	$603K	Buy	1,041 +2	+0.2%	+$1.13K	0.04%	124
2025 Q3	$504K	Buy	1,039 +23	+2%	+$10.7K	0.04%	132
2025 Q2	$412K	Hold	1,016	–	–	0.03%	139
2025 Q1	$529K	Hold	1,016	–	–	0.04%	108
2024 Q4	$529K	Sell	1,016 -22	-2%	-$12.1K	0.04%	108
2024 Q3	$642K	Sell	1,038 -9	-0.9%	-$5.33K	0.05%	90
2024 Q2	$579K	Buy	1,047 +9	+0.9%	+$5.16K	0.05%	90
2024 Q1	$551K	Hold	1,038	–	–	0.05%	89
2023 Q4	$551K	Hold	1,038	–	–	0.05%	89
2023 Q3	$525K	Buy	1,038 +19	+2%	+$10.1K	0.06%	80
2023 Q2	$532K	Sell	1,019 -68	-6%	-$36.7K	0.06%	85
2023 Q1	$627K	Hold	1,087	–	–	0.07%	76
2022 Q4	$599K	Buy	+1,087	New	+$576K	0.08%	80

Other funds holding TMO

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Armstrong Advisory Group's TMO Position: Q3 2026 in Review

Armstrong Advisory Group increased its Thermo Fisher Scientific (TMO) stake by 9% in Q3 2026, buying an estimated $53.5K and bringing the position to 1,095 shares worth $739K. The position accounts for 0.04% of the portfolio, ranked #112.

Armstrong Advisory Group first reported a position in TMO in Q4 2022 and has held it in 16 quarters since. 1,885 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Armstrong Advisory Group held 1,095 shares of Thermo Fisher Scientific worth $739K as of Q3 2026.
Armstrong Advisory Group bought 90 Thermo Fisher Scientific shares in Q3 2026, an estimated $53.5K.
Thermo Fisher Scientific made up 0.04% of Armstrong Advisory Group's portfolio in Q3 2026, its #112 holding.
Armstrong Advisory Group first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 16 quarters since.
1,885 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.